News | August 28, 2007

St. Jude Gets Japanese Approval for Vascular Closure Device

August 29, 2007 - St. Jude Medical Inc. announced that it has received regulatory approval from the Ministry of Health, Labor and Welfare (MHLW), in addition to reimbursement approval, for the Angio-Seal STS Plus Vascular Closure device, strengthening the companies position in the international vascular closure device market.
Angio-Seal STS Plus is designed to provide physicians with an improved method of sealing catheterization sites, allowing patients increased comfort and offering hospitals improved efficiencies. Approved for both percutaneous peripheral and cardiac interventional catheterization procedures, the device enables physicians to quickly seal femoral artery punctures made during those procedures.
According to the manufacturer, with the addition of a self-tightening suture to the design, the Angio-Seal STS Plus allows vascular closure to be completed entirely in the catheterization lab, saving labor and reducing the length of time required to complete the procedure.

For more information: www.sjm.com

Related Content

Vascular Solutions, Teleflex
Feature | December 07, 2016
December 7, 2016 — Teleflex Inc. and Vascular Solutions Inc.
angioseal, angio-seal, terumo, St. Jude, vascular closure devices
News | Vascular Closure Devices| October 18, 2016
October 18, 2016 — Abbott and St. Jude Medical Inc.
Vivasure Medical, Closure Device, Series C financing
News | Vascular Closure Devices| September 12, 2016
September 12, 2016 — Vivasure Medical announced last week that the company has completed a Series C financing of €16.
Rex medical, Closer Vascular Sealing System, VSS, vascular closure, bioresorbable vascular closure device

A close up view of the Rex Medical Closer Vascular Sealing System components.

Technology | Vascular Closure Devices| August 03, 2016
August 3, 2016 — The U.S.
Vivasure Medical, PerQSeal, vascular closure device, CE Mark
News | Vascular Closure Devices| January 18, 2016
Vivasure Medical announced Conformité Européenne (CE) Mark approval of the world’s first fully bioabsorbable...
News | Vascular Closure Devices| December 16, 2015
Scientists at CBSET have presented preclinical evidence that the Manta Large Bore Vascular Closure Device (VCD) from...
Technology | November 06, 2014
Cardinal Health announced that its MynxGrip Vascular Closure Device recently received U.S. Food and Drug Administration...
Videos | Vascular Closure Devices| September 26, 2014
Doug Drachman, M.D., Mass General Hospital Institute of Heart, Vascular and Stroke Care, explains how to prevent and
Feature | September 17, 2014
September 17, 2014 — A new clinical trial found that vascular closure devices (VCDs) are non-inferior to manual...
Cardiva Medical Inc. Vascade Vascular Closure System Series 3 financing U.S.
News | August 21, 2014
Cardiva Medical Inc. said it closed the first two tranches of a $16.5 million Series 3 private equity financing and a $...
Overlay Init